Process View
The process in which a myeloid precursor cell acquires the specialized features of a granulocyte. Granulocytes are a class of leukocytes characterized by the presence of granules in their cytoplasm. These cells are active in allergic immune reactions such as arthritic inflammation and rashes. This class includes basophils, eosinophils and neutrophils.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "granulocyte differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.992 | ||
| CREBBP | CREB binding protein | 0.950 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.545 | ||
| PBX1 | pre-B-cell leukemia homeobox 1 | 0.209 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.191 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.182 | ||
| RUNX1 | runt-related transcription factor 1 | 0.164 | ||
| CUL1 | cullin 1 | 0.155 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.132 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.125 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.114 | ||
| ESR1 | estrogen receptor 1 | 0.096 | ||
| GATA2 | GATA binding protein 2 | 0.094 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.092 | ||
| SH2D4A | SH2 domain containing 4A | 0.081 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.077 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.074 | ||
| EP300 | E1A binding protein p300 | 0.063 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.061 | Human | |
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.052 | ||
| HIC1 | hypermethylated in cancer 1 | 0.051 | ||
| RERE | arginine-glutamic acid dipeptide (RE) repeats | 0.049 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.041 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.041 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.041 | ||
| ATN1 | atrophin 1 | 0.036 | ||
| AR | androgen receptor | 0.035 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.035 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.033 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.027 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.026 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.023 | ||
| FHL1 | four and a half LIM domains 1 | 0.019 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.019 | ||
| TCF4 | transcription factor 4 | 0.019 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.018 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.018 | ||
| TCF12 | transcription factor 12 | 0.017 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.015 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.015 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.015 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.014 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.014 | ||
| SP1 | Sp1 transcription factor | 0.014 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.014 | ||
| HOXA9 | homeobox A9 | 0.012 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.012 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.012 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.011 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | ||
| CTBP1 | C-terminal binding protein 1 | 0.011 | ||
| CREB1 | cAMP responsive element binding protein 1 | 0.011 | ||
| HDAC6 | histone deacetylase 6 | 0.010 | ||
| MAGEA11 | melanoma antigen family A, 11 | 0.010 | ||
| SUV39H1 | suppressor of variegation 3-9 homolog 1 (Drosophila) | 0.010 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.010 |